Morgan Stanley has started coverage on the digital payments startup with an overweight rating and a price target of 1,875 rupees, which implies 43% upside from Tuesday's close
Snapdeal receives more than 86 per cent of its orders from outside metros
The company is planning to file preliminary documents as soon as the first quarter of 2022
CMS provides cash management services, which include ATM services, and cash delivery and pick-up
MapmyIndia, which powers Apple Inc's maps in the country, surged 54% in its market debut on Tuesday following a bumper initial public offering subscription last week
The company has allotted 1.53 crore equity shares to 12 anchor investors at Rs 216 apiece
The initial public offer of Supriya Lifescience Limited was subscribed 71.47 times on the last day of share sale on Monday. The initial share sale received bids for 1,03,83,31,980 shares against 1,45,28,299 shares on offer, according to NSE data. The category for non-institutional investors received 161.22 times subscription, while those for Retail Individual Investors (RIIs) was subscribed 55.77 times and Qualified Institutional Buyers (QIBs) 31.83 times. The initial public offer (IPO) of Supriya Lifescience was fully subscribed within a few hours of opening for subscription on Thursday on the back of a strong response from retail investors. The IPO had a fresh issue of up to Rs 200 crore and an offer for sale of up to Rs 500 crore. It had a price range of Rs 265-274 per share. The company on Wednesday raised Rs 315 crore from anchor investors. The proceeds from the fresh issue will be used for funding capital expenditure requirements, debt repayment, and general corporate ...
The government on Sunday refuted media speculation around the IPO of LIC and said that it is unlikely to come up with the IPO of LIC in the current financial year ending March 2022
The initial share sale of Supriya Lifescience Limited received 5.69 times subscription on the second day of offer on Friday. The initial public offer (IPO) received bids for 8,27,05,698 shares against 1,45,28,299 shares on offer, as per NSE data. The category for Retail Individual Investor (RIIs) was subscribed 25.38 times, while non-institutional investors received 2.90 times subscription, and Qualified Institutional Buyers (QIBs) 53 per cent. The initial public offer of Supriya Lifescience was fully subscribed within a few hours of opening for subscription on Thursday on the back of a strong response from retail investors. The initial public offer has a fresh issue of up to Rs 200 crore and an offer-for-sale of up to Rs 500 crore. Price range for the offer is at Rs 265-274 per share. On Wednesday, the company raised Rs 315 crore from anchor investors. The proceeds from the fresh issue will be used for funding capital expenditure requirements, debt repayment, and general corpor
The IPO received bids for 20,303,100 shares against 2,528,500 shares on offer
The company is looking to raise INR 34.2 crore from this public issue.
Ola, which has a majority share of India's ride-hailing market where it competes with Uber Technologies, has plans to raise up to $1 billion through an initial public offering.
IPO rush encourages early stage investor to dial-up deals up to Series C rounds
SBI currently holds 63 per cent stake in the mutual fund company and the remaining 37 per cent stake is held by AMUNDI Asset Management through a wholly owned subsidiary, Amundi India Holding
A decision to shift to Hong Kong was made after regulatory approval for FWD's planned U.S. IPO of $2 billion to $3 billion was delayed.
Sources said an official announcement would be made to the Hong Kong Stock Exchange shortly
Investors are turning increasingly skeptical about IPOs as a record year for Indian listings draws to a close
Data Patterns (India), which supplies electronic systems to defence and aerospace sector, on Thursday said it has fixed a price band of Rs 555-585 a share for its Rs 588 crore initial public offering
South Korean biopharmaceutical firm SK Bioscience's IPO raised $1.3 billion for the firm, which is a local Covid-19 vaccine-production partner with AstraZeneca Plc.
Inox Wind on Monday said the board of its arm Inox Green Energy Services Ltd has approved fund raising of Rs 500 crore through an initial public offering of its equity shares